Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription.
Molecular and cellular endocrinology Jul, 2010 | Pubmed ID: 20302909